Volume 93, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Hemoglobin E is largely confined to south and southeast Asia. The association between hemoglobin E (HbE) and malaria is less clear than that of hemoglobin S and C. As part of a malaria study in the Chittagong Hill Districts of Bangladesh, an initial random sample of 202 individuals showed that 39% and 49% of Marma and Khyang ethnic groups, respectively, were positive for either heterozygous or homozygous hemoglobin E. In this group, 6.4% were also found to be severely deficient and 35% mildly deficient for glucose-6-phosphate dehydrogenase (G6PD). In a separate malaria case–uninfected control study, the odds of having homozygous hemoglobin E (HbEE) compared with normal hemoglobin (HbAA) were higher among malaria cases detected by passive surveillance than age and location matched uninfected controls (odds ratio [OR] = 5.0, 95% confidence interval [CI] = 1.07–46.93). The odds of heterozygous hemoglobin E (HbAE) compared with HbAA were similar between malaria cases and uninfected controls (OR = 0.71, 95% CI = 0.42–1.19). No association by hemoglobin type was found in the initial parasite density or the proportion parasite negative after 2 days of artemether/lumefantrine treatment. HbEE, but not HbAE status was associated with increased passive case detection of malaria.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Agarwal A, Guindo A, Cissoko Y, Taylor JG, Coulibaly D, Kone A, Kayentao K, Djimde A, Plowe CV, Doumbo O, Wellems TE, Diallo D, , 2000. Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a west African population with a low prevalence of hemoglobin S. Blood 96: 23582363. [Google Scholar]
  2. Modiano D, Luoni G, Sirima BS, Simpore J, Verra F, Konate A, Rastrelli E, Olivieri A, Calissano C, Paganotti GM, D'Urbano L, Sanou I, Sawadogo A, Modiano G, Coluzzi M, , 2001. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 414: 305308.[Crossref] [Google Scholar]
  3. Mockenhaupt FP, Ehrhardt S, Cramer JP, Otchwemah RN, Anemana SD, Goltz K, Mylius F, Dietz E, Eggelte TA, Bienzle U, , 2004. Hemoglobin C and resistance to severe malaria in Ghanaian children. J Infect Dis 190: 10061009.[Crossref] [Google Scholar]
  4. May J, Evans JA, Timmann C, Ehmen C, Busch W, Thye T, Agbenyega T, Horstmann RD, , 2007. Hemoglobin variants and disease manifestations in severe falciparum malaria. JAMA 297: 22202226.[Crossref] [Google Scholar]
  5. Williams TN, Mwangi TW, Wambua S, Alexander ND, Kortok M, Snow RW, Marsh K, , 2005. Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis 192: 178186.[Crossref] [Google Scholar]
  6. Fucharoen S, Winichagoon P, , 1987. Hemoglobinopathies in southeast Asia. Hemoglobin 11: 6588.[Crossref] [Google Scholar]
  7. Naka I, Ohashi J, Nuchnoi P, Hananantachai H, Looareesuwan S, Tokunaga K, Patarapotikul J, , 2008. Lack of association of the HbE variant with protection from cerebral malaria in Thailand. Biochem Genet 46: 708711.[Crossref] [Google Scholar]
  8. Williams TN, , 2006. Human red blood cell polymorphisms and malaria. Curr Opin Microbiol 9: 388394.[Crossref] [Google Scholar]
  9. Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Brittenham G, Looareesuwan S, Clark AG, Tokunaga K, , 2004. Extended linkage disequilibrium surrounding the hemoglobin E variant due to malarial selection. Am J Hum Genet 74: 11981208.[Crossref] [Google Scholar]
  10. Haldane J, , 1949. The rate of mutation of human genes. Hereditas 35: 267273.[Crossref] [Google Scholar]
  11. Hutagalung R, Wilairatana P, Looareesuwan S, Brittenham GM, Aikawa M, Gordeuk VR, , 1999. Influence of hemoglobin E trait on the severity of falciparum malaria. J Infect Dis 179: 283286.[Crossref] [Google Scholar]
  12. Oo M, Tin S, Marlar T, O'Sullivan WJ, , 1995. Genetic red cell disorders and severity of falciparum malaria in Myanmar. Bull World Health Organ 73: 659665. [Google Scholar]
  13. Hutagalung R, Wilairatana P, Looareesuwan S, Brittenham GM, Gordeuk VR, , 2000. Influence of hemoglobin E trait on the antimalarial effect of artemisinin derivatives. J Infect Dis 181: 15131516.[Crossref] [Google Scholar]
  14. Ahmed S, Galagan S, Scobie H, Khyang J, Prue CS, Khan WA, Ram M, Alam MS, Haq MZ, Akter J, Glass G, Norris DE, Nyunt MM, Shields T, Sullivan DJ, Sack DA, , 2013. Malaria hotspots drive hypoendemic transmission in the Chittagong Hill Districts of Bangladesh. PLoS One 8: e69713.[Crossref] [Google Scholar]
  15. Khan WA, Sack DA, Ahmed S, Prue CS, Alam MS, Haque R, Khyang J, Ram M, Akter J, Nyunt MM, Norris D, Glass G, Shields T, Haq MZ, Cravioto A, Sullivan DJ, Jr, 2011. Mapping hypoendemic, seasonal malaria in rural Bandarban, Bangladesh: a prospective surveillance. Malar J 10: 124.[Crossref] [Google Scholar]
  16. Khim N, Benedet C, Kim S, Kheng S, Siv S, Leang R, Lek S, Muth S, Chea N, Chuor CM, Duong S, Kerleguer A, Tor P, Chim P, Canier L, Witkowski B, Taylor WR, Menard D, , 2013. G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients. Malar J 12: 171.[Crossref] [Google Scholar]
  17. Team RR, 2008. A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. [Google Scholar]
  18. Alperin JB, Dow PA, Petteway MB, , 1977. Hemoglobin-A2 levels in health and various hematologic disorders. Am J Clin Pathol 67: 219226.[Crossref] [Google Scholar]
  19. Billo MA, Johnson ES, Doumbia SO, Poudiougou B, Sagara I, Diawara SI, Diakite M, Diallo M, Doumbo OK, Tounkara A, Rice J, James MA, Krogstad DJ, , 2012. Sickle cell trait protects against Plasmodium falciparum infection. Am J Epidemiol 176 (Suppl 7): S175S185.[Crossref] [Google Scholar]
  20. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu NH, Htut Y, Han KT, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi OO, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Ghose A, Hossain MA, Samad R, Rahman MR, Hasan MM, Islam A, Miotto O, Amato R, MacInnis B, Stalker J, Kwiatkowski DP, Bozdech Z, Jeeyapant A, Cheah PY, Sakulthaew T, Chalk J, Intharabut B, Silamut K, Lee SJ, Vihokhern B, Kunasol C, Imwong M, Tarning J, Taylor WJ, Yeung S, Woodrow CJ, Flegg JA, Das D, Smith J, Venkatesan M, Plowe CV, Stepniewska K, Guerin PJ, Dondorp AM, Day NP, White NJ, , 2014. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371: 411423.[Crossref] [Google Scholar]
  21. Starzengruber P, Swoboda P, Fuehrer HP, Khan WA, Hofecker V, Siedl A, Fally M, Graf O, Teja-Isavadharm P, Haque R, Ringwald P, Noedl H, , 2012. Current status of artemisinin-resistant falciparum malaria in south Asia: a randomized controlled artesunate monotherapy trial in Bangladesh. PLoS One 7: e52236.[Crossref] [Google Scholar]
  22. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, Consortium AS, , 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359: 26192620.[Crossref] [Google Scholar]
  23. Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B, Rutvisuttinunt W, Bethell D, Surasri S, Fukuda MM, Socheat D, Thap LC, , 2010. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in southeast Asia. Clin Infect Dis 51: E82E89.[Crossref] [Google Scholar]
  24. Li QG, O'Neil M, Xie LS, Caridha D, Zeng Q, Zhang J, Pybus B, Hickman M, Melendez V, , 2014. Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections. Malar J 13: 141.[Crossref] [Google Scholar]
  25. Fernando D, Rodrigo C, Rajapakse S, , 2011. Primaquine in vivax malaria: an update and review on management issues. Malar J 10: 351.[Crossref] [Google Scholar]
  26. Global Malaria Programme, 2012. Single Dose Primaquine as a Gametocytocide in Plasmodium falciparum Malaria. Available at: http://www.who.int/malaria/mpac/sep2012/en/. [Google Scholar]

Data & Media loading...

  • Received : 07 Oct 2014
  • Accepted : 16 Apr 2015
  • Published online : 05 Aug 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error